Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma
Medullary thyroid carcinoma occurs in both sporadic (75%) and hereditary (25%) forms. The missense mutations of RET proto-oncogene in MTC development have been well demonstrated. To investigate the spectrum of predominant RET germline mutations in exons 10, 11, and 16 in hereditary MTC in Iranian po...
Main Authors: | Mehdi Hedayati, Marjan Zarif Yeganeh, Sara Sheikhol Eslami, Shekoofe Rezghi Barez, Laleh Hoghooghi Rad, Fereidoun Azizi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2011-01-01
|
Series: | Journal of Thyroid Research |
Online Access: | http://dx.doi.org/10.4061/2011/264248 |
Similar Items
-
Germline mutation of RET proto-oncogene’s exons 17 and 18 in Iranian medullary thyroid carcinoma patients
by: Marjan Zarif Yeganeh, et al.
Published: (2017-03-01) -
Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.
by: Sara Sheikholeslami, et al.
Published: (2014-02-01) -
The frequency of G691S/S904S Haplotype of RET proto-oncogene in medullary thyroid carcinoma patients in Iranian population
by: Sara Sheikholeslami, et al.
Published: (2014-11-01) -
Germline mutation of exon 19 of RET proto-oncogene in an Iranian population with Medullary thyroid cancer
by: Hoda Golab Ghadaksaz, et al.
Published: (2015-09-01) -
Plasma levels of calcitonin in medullary thyroid carcinoma patients with and without the RET proto-oncogene mutations in exons 10 and 11
by: Samira Ehyayi, et al.
Published: (2017-09-01)